These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3066587)

  • 1. Human erythrocyte complement receptor type one (CR1): expression, function and role in the pathogenesis of inflammatory connective tissue diseases.
    Thomsen BS
    Dan Med Bull; 1988 Oct; 35(5):414-22. PubMed ID: 3066587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.
    Dobson NJ; Lambris JD; Ross GD
    J Immunol; 1981 Feb; 126(2):693-8. PubMed ID: 7005341
    [No Abstract]   [Full Text] [Related]  

  • 6. C3b receptor (CR1) on erythrocytes in various diseases.
    Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
    Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A preliminary study on the immune function of human red cells].
    Guo F
    Zhonghua Yi Xue Za Zhi; 1982 Dec; 62(12):715-6. PubMed ID: 6220797
    [No Abstract]   [Full Text] [Related]  

  • 9. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
    Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
    Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor 1 gene polymorphisms in sarcoidosis.
    Zorzetto M; Bombieri C; Ferrarotti I; Medaglia S; Agostini C; Tinelli C; Malerba G; Carrabino N; Beretta A; Casali L; Pozzi E; Pignatti PF; Semenzato G; Cuccia MC; Luisetti M
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):17-23. PubMed ID: 12091241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
    Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
    Walport MJ; Lachmann PJ
    Arthritis Rheum; 1988 Feb; 31(2):153-8. PubMed ID: 3279961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of immune complexes using C3 receptors on human erythrocytes].
    Aikawa T; Tanimoto K
    Rinsho Byori; 1986 Oct; Spec No 69():77-84. PubMed ID: 3543440
    [No Abstract]   [Full Text] [Related]  

  • 16. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).
    Repik A; Pincus SE; Ghiran I; Nicholson-Weller A; Asher DR; Cerny AM; Casey LS; Jones SM; Jones SN; Mohamed N; Klickstein LB; Spitalny G; Finberg RW
    Clin Exp Immunol; 2005 May; 140(2):230-40. PubMed ID: 15807846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies in connective tissue diseases].
    Mimori T
    Nihon Rinsho; 2005 May; 63 Suppl 5():187-92. PubMed ID: 15954347
    [No Abstract]   [Full Text] [Related]  

  • 18. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
    Taylor RP; Sutherland WM; Martin EN; Ferguson PJ; Reinagel ML; Gilbert E; Lopez K; Incardona NL; Ochs HD
    J Immunol; 1997 Jan; 158(2):842-50. PubMed ID: 8993002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
    Beynon HL; Davies KA; Haskard DO; Walport MJ
    J Immunol; 1994 Oct; 153(7):3160-7. PubMed ID: 8089493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.